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At a Glance Commentary 
 
Scientific Knowledge on the Subject 
 
Increased airway resistance during inspiration, triggers lung, diaphragm and systemic 
inflammation, alveolar-capillary barrier dysfunction, deranges respiratory mechanics and 
induces acute lung injury. 
What This Study Adds to the Field 
 
In previously healthy lungs increasing both the inspiratory and expiratory airway 
resistance, via tracheal banding induces lung barrier dysfunction and inflammation and 
downregulates the guanylyl cyclase expression. Pharmacological prevention or 
restoration of the decline of guanylyl cyclase pathway activity attenuates the resistive 
breathing induced lung injury, unravelling a potential therapeutic application in 
obstructive airway diseases. 
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Abstract 
 
Rationale: Inspiratory resistive breathing (RB), encountered in obstructive lung diseases, 
induces lung injury. Soluble Guanylyl Cyclase (sGC)/cGMP pathway is downregulated in 
chronic and acute animal models of RB such as asthma, COPD and in endotoxin-induced 
acute lung injury. Objectives: i) To characterize the effects of increased concurrent 
inspiratory and expiratory resistance in mice, via tracheal banding, ii) To investigate the 
contribution of the sGC/cGMP pathway in in RB-induced lung injury. Methods and 
Main Results: Anesthetized C57BL/6 mice underwent RB achieved by restricting 
tracheal surface area to 50% (tracheal banding). RB for 24 hours resulted in increased 
bronchoalveolar lavage fluid cellularity and protein content, in marked leukocyte 
infiltration in the lungs and perturbed respiratory mechanics (increased tissue resistance 
and elasticity, shifted static pressure volume curve right and downwards, decreased static 
compliance), consistent with the presence of acute lung injury. RB downregulated the 
sGC expression in the lung. All manifestations of lung injury caused by RB were 
exacerbated by the administration of the sGC inhibitor, ODQ, or when RB was performed 
using sGC α1 knockout mice. Conversely, restoration of sGC signalling by prior 
administration of the sGC activator BAY 58-2667 prevented the RB-induced lung injury. 
Strikingly, direct pharmacological activation of sGC with BAY 58-2667 24h post-RB 
reversed, within 6 hours, the established lung injury. Conclusions: These findings raise 
the possibility that pharmacological targeting of the sGC/cGMP axis could be used to 
ameliorate lung dysfunction in obstructive lung diseases. 
Abstract Word Count: 235 
 
Keywords: Lung Injury, Tracheal Banding, Soluble Guanylyl Cyclase. 
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INTRODUCTION 
 
Acute increases in airway resistance (Acute Resistive Breathing (ARB) is 
encountered in many disease states such as asthma attacks, COPD exacerbations and 
upper airway obstruction. During ARB, strenuous contractions of the inspiratory muscles 
lead to large negative swings in the intrathoracic pressures that may induce injurious 
mechanical stress in resident lung cells. We have shown that increased airway resistance 
during inspiration increases alveolar-capillary membrane permeability, triggers lung 
inflammation, perturbs the mechanics of the respiratory system and induces acute lung 
injury in the lungs of previously healthy rats (1). However, in that model there was no 
expiratory resistance. It has been suggested that the presence of expiratory resistance with 
its accompanying intrinsic PEEP would oppose, during expiration, the forces producing 
pulmonary edema during inspiration secondary to the large negative intrathoracic 
pressures developed (2). We thus developed a murine-mouse model of ARB exhibiting 
both increased inspiratory and expiratory airway resistance, via tracheal banding. We 
hypothesized that increasing both the inspiratory and the expiratory airway resistance 
would cause injury to the lung, similar to purely inspiratory RB (1), on the premise that 
the structurally injurious processes during inspiration cannot be repaired or counteracted 
during expiration. The model of tracheal banding is most consistent with acute fixed 
upper airway obstruction, which is of course different than the obstructive patterns seen 
in COPD due to loss of alveoli and elasticity as well as the typically small airway 
constriction in asthma. In both of these disorders there is, in general, more difficulty with 
expiration than with inspiration.  Having said that tracheal banding is the only way we are 
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aware of to acutely increase airway resistance without affecting the underlying airway 
inflammation (i.e. to induce pure mechanical acute resistive breathing). 
Soluble Guanylyl Cyclase (sGC) mediates a wide range of physiological effects 
by catalyzing the conversion of GTP to cGMP (3). sGC is downregulated in animal 
models of both resistive breathing, such as COPD (4) or allergic asthma (5) and acute 
lung injury, such as endotoxin inhalation (6) or ischemia-reperfusion (7). Treatment of 
cultured cells with lipopolysaccharide, interleukin-1β, cytokine mixtures or uncontrolled 
production of NO and reactive oxygen species (ROS), decreases the mRNA stability and 
protein expression of both sGC subunits (α1 and β1), leading to sGC/cGMP pathway 
dysfunction (5, 6, 8, 9). In mice, TNF-α contributes to the downregulation of sGC 
expression in LPS-induced lung injury (6). Since cytokines and ROS -upregulated in the 
lung (1) and systemically (10, 11) during inspiratory RB- can reduce sGC expression, we 
hypothesised that RB would reduce sGC lung levels. Furthermore we investigated the 
functional role of sGC during RB, by activating the enzyme using BAY 58-2667, which 
protects the enzyme from proteolytic breakdown and reactivates cGMP production (12). 
We hypothesised that stabilization of sGC and restoration of its downstream signalling 
would ameliorate manifestations of acute lung injury due to RB. 
 
 
 
METHODS 
 
Methodological details are available in the online data supplement. 
 
Subjects: Eight-to-twelve-week old male C57BL/6 mice, were purchased from Pasteur 
Institute (Athens, Greece). sGC α1-/- mice, were provided by the SPF facility of the 
Department of Molecular Biomedical Research, VIB, Ghent, Belgium. 
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Tracheal Banding (RB) protocol: Anesthetized C57BL/6 mice underwent RB by placing 
surgically a sterile nylon band around the extrathoracic trachea restricting tracheal surface 
area to 50%. Sham surgery of control mice consisted of anesthesia, neck incision, and 
tracheal dissection without banding. 
Respiratory System Mechanics: Forced Oscillation Technique – i)Constant phase model, 
ii)Static Pressure Volume Curve. Respiratory system mechanics were estimated with the 
use of the forced oscillation technique and by performing static pressure volume curves 
(1). 
Bronchoalveolar lavage (BAL) fluid: Bronchoalveolar lavage was performed, total and 
differential cell counts were obtained and protein content was estimated (6). 
Lung Histology: The left lung was harvested and stained with hematoxylin-eosin. Lung 
histopathology was evaluated using a scoring system to grade the degree of 
inflammation(13). 
cGMP measurements. cGMP production was measured in BALF, collected 24hrs after 
RB(4). 
Quantitative real-time PCR. Total RNA was extracted from lungs, cDNA was 
synthesized and target and reference genes were measured by real-time PCR using 
custom designed primers(4). 
Immunoblot analysis of sGC subunits: Samples of lung homogenates were subjected to 
SDS-PAGE and Western blotting. Values obtained for the α1 and β1 sGC subunit were 
normalized for actin and presented as % of control (4-6). 
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ODQ treatment: C57BL/6 mice were treated with inhaled ODQ (1H-[1, 
2,4]oxodiazolo[4,3-]quinoxalin-l-one; 1 mg/mL: 5 mg ODQ diluted in 50µL DMSO and 
then further dissolved in 5 ml saline ) or vehicle, 30 min before RB. 
8pCPT cGMP treatment: C57BL/6 mice were treated with inhaled 8pCPT cGMP 
(2g/mL: 10 mg 8pCPT cGMP diluted in 50µL DMSO and then further dissolved in 5 ml 
saline) or vehicle, 30 min before RB. 
BAY 58-2667 treatment: C57BL/6 mice were treated with the sGC activator BAY 58- 
2667 (10µg/kg, i.p.) or vehicle 30 min before (prophylactic protocol) or 24 hrs after RB 
(therapeutic protocol). 
Statistical analysis: Results are presented as means± SEM. ANOVA was performed with 
SPSS 11.5 software. Differences were considered significant when p<0.05. 
 
 
 
RESULTS 
 
RB via tracheal banding in wild type mice: 
 
BALF protein and cell count. In RB mice with 50% reduction in tracheal surface area 
(see online supplement, Figure E1), BALF cellularity was increased compared to the 
control group, mainly due to macrophage influx (macrophages: 91% of total cell count) 
(Figure 1A). BALF protein content was increased after RB (Figure 1C). BALF cytokines. 
Acute RB increased BALF levels of TNF-α (Figure 1D), IL-6 (Figure 1E) and IL- 
1β(Figure 1F) in mice. Lung Histology: RB increased interstitial and intraalveolar 
infiltration and focal thickening in the lung tissue (Figure 1G and H) and thus total lung 
injury score. Respiratory System Mechanics: Tissue resistance and elasticity were 
increased after RB. RB shifted the static pressure volume curve right and downwards 
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consistent with the presence of lung injury. Accordingly, static compliance was decreased 
(Figure 1 I, J, and K). 
 
 
 
Tracheal banding reduces the expression of soluble guanylyl cyclase 
 
mRNA and Protein levels for the sGC subunits are decreased in the lungs of TB mice. 
After RB the mRNA levels of the sGC β1 subunit were reduced (Figure 2A). Western 
blotting analysis (Figure 2C) revealed that the expression of both the α1 and β1 protein 
subunits were reduced after RB (Figure 2D). cGMP measurement: To determine whether 
attenuated sGC levels are reflected by impaired enzyme function after RB, we measured 
total cGMP levels in the BALF. RB resulted in reduced cGMP levels compared to 
controls (Figure 2B). Conversely, phosphodiesterase (PDE)-5, which hydrolyses cGMP 
to GMP, was increased after RB (Figure E3). 
 
Inhibition of sGC activity by ODQ worsens RB-induced lung injury: To determine the 
effects of inhibition sGC activity during RB-induced acute lung injury, the sGC inhibitor 
ODQ was administered by inhalation 30min prior to RB (Figure 3). BALF protein and 
cell count: Sham-operated animals treated with ODQ, did not increase BALF cellularity. 
In contrast, when ODQ was administered prior to RB, it increased BALF cellularity and 
protein content compared to the RB-only group (Figure 3A and B). Lung Histology: The 
total lung injury score after RB was exacerbated by prior administration of ODQ (Figure 
3C and D). Respiratory System Mechanics: ODQ aggravated the effects of RB on airway 
resistance and tissue elasticity (Figure 3E and F). 
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sGC α1 deficiency in mice aggravates RB-induced lung injury. To determine the role of 
sGC downregulation in lung inflammation and respiratory system mechanics in our 
model, we compared sGCα1-/- and WT mice after tracheal banding. All basal parameters 
of lung injury and inflammation were similar between sham-operated WT and sGC α1-/- 
mice. BALF protein and cell count: In sGCα1-/- mice, RB increased BALF cellularity 
mainly due to macrophages influx and aggravated barrier dysfunction, as reflected by the 
further increase in the BALF protein content, compared to WT mice (Figure 4A and B). 
Lung Histology: sGC α1-/- mice subjected to RB exhibited increased interstitial and 
intraalveolar infiltration and focal thickening in the lung tissue compared to WT mice 
(Figure 4C and D). Respiratory System Mechanics: sGCα1-/- mice exhibit exacerbated 
derangements of airway resistance and tissue elasticity after RB (Figure 4E and F). 
 
Restoration of sGC downstream signalling:  Activation of sGC using BAY 58-2667 
 
 
 
A. Prophylactic administration of sGC activator BAY 58-2667 attenuated the RB- 
induced lung injury. To evaluate the protective effect of restoration of sGC downstream 
signalling, an NO-and heme independent sGC activator, BAY 58-2667 was administrated 
30min prior to tracheal banding (Figure 5; schematic overview of the protocol in the 
Figure E6D). Prophylactic administration of BAY 58-2667 reversed the RB-induced 
attenuation of cGMP levels (see online supplement, Figure E5A). BALF protein and cell 
count: BALF cellularity was increased after RB. Prophylactic administration of BAY 
58-2667 reduced BALF cellularity (Figure 5A). BALF protein content was increased 
after RB compared to the sham operated group. Prophylactic administration of BAY 58- 
2667 reduced BALF protein content to control level (Figure 5B). Lung Histology: Total 
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lung injury score was increased after RB, whereas prophylactic administration of BAY 
58-2667, reduced interstitial and intraalveolar infiltration and focal thickening in the lung 
tissue, compared to RB mice (Figure 5C and D). Respiratory System Mechanics: 
Prophylactic administration (i.p.) of BAY 58-2667 attenuated the effects of RB on airway 
resistance and tissue elasticity (Figure 5E and F). 
 
B. Therapeutic administration of sGC activator BAY 58-2667 attenuated the RB- 
induced lung injury. To test a putative therapeutic effect of the sGC activation, BAY 58- 
2667, was administrated i.p., 24 hrs after tracheal banding and mice were euthanized 6h 
after BAY administration (schematic overview of the protocol in E6D). Therapeutic 
administration of BAY 58-2667 reversed the RB-induced attenuation of cGMP levels 
(see online supplement, Figure E5B). BALF protein and cell count: Therapeutic 
treatment of mice with BAY 58-2667 reversed the increases in BALF cellularity induced 
by RB to control levels (Figure 6A). However, this treatment did not reverse the 
compromise of the barrier function, since it had no effect the increase in BALF protein 
content evoked by RB (Figure 8B). Lung Histology: Therapeutic administration of BAY 
58-2667, reduced interstitial and intraalveolar infiltration and focal thickening in the lung 
tissue, compared to RB mice (Figure 6C and D). Respiratory System Mechanics: 
Therapeutic administration of BAY 58-2667 attenuated the effect of RB on airway 
resistance and tissue elasticity. (Figure 6E and F). 
 
DISCUSSION 
 
 
 
The major findings are: 1) concurrent inspiratory and expiratory RB (via tracheal 
banding) induces acute lung injury in mice; 2) RB induces downregulation of sGC; 3) 
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pharmacological inhibition or genetic ablation of the sGC aggravates the RB-induced 
lung injury; 4) pharmacological rescue of the guanylyl cyclase signalling dysfunction, 
using a sGC activator (BAY 58-2667), attenuates the RB-induced lung injury; 5) 
stabilization of sGG by administration of BAY 58-2667 after the establishment of lung 
injury, reverses RB-induced lung injury. 
 
Strenuous inspiratory RB in healthy humans induces plasma IL-1β, IL-6 and 
TNF-α, initiating a systemic inflammatory response (10, 11). Inspiratory RB in rats 
increases alveolar-capillary membrane permeability, induces lung inflammation and 
perturbs respiratory system mechanics, culminating in acute lung injury (1). In both the 
animal and the human models there was no expiratory resistance, contrary to what is 
observed in asthma attacks, COPD exacerbations or cases of upper airway obstruction. It 
has been suggested that the presence of expiratory resistance with its accompanying 
intrinsic PEEP would prevent pulmonary edema development (2). 
 
We thus developed a mouse model of resistive breathing which exhibits increased 
both inspiratory and expiratory airway resistance, via tracheal banding. We studied mice 
for two reasons: to determine whether our previous findings were species-specific and to 
establish a clinically relevant model of RB in mice, which allows for the study of 
genetically engineered animals. 
Acute RB for 24 hours increased BALF cellularity mainly due to an increase in 
macrophages, consistent with acute inflammation. In addition, lung histology revealed 
patchy areas of inflammatory cell recruitment, alveolar hemorrhage, intra-alveolar and 
interstitial  edema.  The  pro-inflammatory cytokines  TNF-α,  IL-6  or  IL-1β  were  also 
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elevated in the BALF. These might originate from infiltrating leukocytes and/or might be 
produced from cells resident in the lung via “mechanotransduction” or in response to 
other locally produced stimuli. Acute RB in mice was followed by increased tissue 
elasticity and resistance and downward shift of the pressure-volume curve. Accordingly, 
static compliance was decreased. These alterations are well described in acute lung 
injury and elasticity increases have been previously correlated with lung injury (1, 14, 
15). Thus, the presence of expiratory resistance did not prevent lung injury, probably 
because the structurally injurious processes in the lung during inspiration can not be 
repaired or counteracted during expiration. 
 
The current findings in mice, combined with our recent ones in rats, suggest that 
the RB-induced lung injury is not species-specific. One might wonder whether the degree 
of airway narrowing in our model was excessive or was within the pathophysiologically 
relevant range. The negligible mortality of both wild type and transgenic mice after 
tracheal banding clearly allows this technique developed in our laboratory, to be used for 
acute experiments in both normal and genetically engineered mice, provided that, similar 
to our knock-out murine line (sGCa1 -/-), they do not already exhibit increased baseline 
inflammation and respiratory dysfunction. We still need to investigate whether this 
approach can be used with murine lines that have compromised respiratory function. 
 
RB resulted in the attenuation of the sGC/cGMP signal cascade. After 24hrs of 
tracheal banding, mRNA levels of the sGCβ1 subunit were drastically reduced. As sGC is 
an obligate heterodimer, decreased levels of β1 subunit indicate a decline in the amount 
of the active enzyme (16). Western blot analyses revealed that both α1 and β1 subunits 
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were reduced after 24 hours of RB. Moreover, phosphodiesterase-5 (PDE-5), which 
hydrolyses cGMP to GMP, terminating its action, was increased with RB, further 
impairing sGC/cGMP downstream pathway, in agreement to our previous findings in 
mice exposed to cigarette smoke (4). Our model of RB distinguishes the 
mechanotransductive effect of the increased airway resistance (i.e. tracheal banding in 
previously healthy lungs, the mechanical stressor) on sGC signalling from the underlying 
airway inflammation of obstructive airway diseases (i.e asthma and COPD which also 
have increased airway resistance, yet with pre-existing underlying airway inflammation). 
This is the first time that downregulation of sGC expression is shown in the lung 
secondary to the mechanotransductive effect of RB. 
 
Treatment of cultured cells with inflammatory stimuli attenuates the sGC mRNA 
stability or protein expression (17-20). Increased inflammation and TNF-α, IL-6 or IL-1β 
upregulation was documented in the BALF of mice after RB. However, an alternative 
explanation for the reduction of the sGC levels that is not mutually exclusive with the 
increase in cytokines is mechanotransduction, i.e. increased mechanical stress on the 
resident lung cells due to the large negative intrathoracic pressures developed. 
Oxidative stress along with inflammatory stimuli could impair sGC signalling due 
to acute RB. We treated animals with ODQ, an agent that selectively oxidizes sGC prior 
to RB. This resulted in augmented inflammation, vascular leakage and mechanical 
derangements. Our data is consistent with a previous study of endotoxin induced-lung 
injury where oxidation of sGC and further attenuation of its enzymatic activity using 
ODQ caused increased inflammation and vascular leakage (21). In support of this 
hypothesis,  we  have  previously  observed  that  inhibition  of  sGC  by  ODQ  was 
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accompanied by more pronounced bronchial responsiveness in an asthma model (5) and 
lung barrier dysfunction in the LPS-induced lung injury model (6). We investigated the 
role of sGC downstream signalling in RB-induced lung injury using sGCα1 knock-out 
mice subjected to tracheal banding. In these adult sGCα1 knock-out mice sGC β1 subunit 
lung levels are decreased (22). RB-induced lung injury was more pronounced when 
sGC/cGMP signalling was impaired due to sGCα1 subunit knock-out, reinforcing the 
notion that sGC signalling protects lung integrity. Interestingly, no difference in BALF 
cellularity, protein content or mechanical properties was observed between sham operated 
wild type and sGCα1 knockout mice. It seems that at basal conditions in uninjured 
animals the α2β1 isoform of the sGC is able to maintain downstream signalling 
pathways. However, during RB via tracheal banding, sGC α1β1 appeared to play a 
crucial role. 
 
To elucidate the effect of sGC activity in RB-induced lung injury, wild type mice 
were treated with the heme- and NO-independent sGC activator BAY 58-2667 30 
minutes before tracheal banding (prophylactic protocol). Prophylactic administration of 
BAY 58-2667 preferentially protects against diseases characterized by marked oxidative 
injury, such as pulmonary hypertension (23) or cardiovascular diseases (24, 25) by 
activating the NO-insensitive, oxidized form of sGC. We observed that prophylactic 
administration of BAY 58-2667 attenuated the RB-induced lung injury by reducing to 
control levels the BALF cellularity and protein content, and improving airway resistance 
and tissue elasticity. 
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To investigate the functional role of the sGC downstream signalling, a cGMP 
analogue (8pCPTcGMP) was administered prior to RB. PKG activation by 8pCPTcGMP 
attenuated the RB-induced increase in BALF cellularity and protein content (see online 
supplement, Figure E3). The elevated cytokine response to RB was almost abolished after 
inhalation of 8pCPTcGMP (see online supplement, Figure E4). Lung mechanics 
perturbation was also entirely prevented (see online supplement, Figure E3). Since 
restoring sGC downstream signalling by 8pCPTcGMP administration attenuated the lung 
injury caused by RB, we propose that downregulation of sGC is causally related to the 
observed lung injury rather than the result of it. 
 
To investigate whether restoration of sGC/cGMP signalling could be effective in a 
clinically meaningful manner, we administered BAY 58-2667 after 24 hours of tracheal 
banding, when injury is well-established and examined the animals 6 hours later 
(therapeutic protocol). Strikingly, therapeutic administration of BAY 58-2667 reversed 
the RB-induced lung injury, attenuated BALF cellularity and improved the mechanical 
parameters. Thus, guanylyl cyclase exerts a causative role in the pathological alterations 
and mechanical derangements in our model of RB, and restoration of its activity has 
therapeutic potential. 
 
The protective effect of sGC signalling in our RB model is consistent with 
observations on the endothelial barrier (21). The sGC stimulator BAY 41-2272 reduces 
the elevated leukocyte rolling and adhesion in the capillaries of eNOS -/- mice (26). sGC 
stimulation inhibits the IL-1β-induced increase in leukocyte adhesion by attenuating P- 
selectin expression (26). Increasing intracellular cGMP, by 8pCPT-cGMP administration, 
Page 15 of 50  AJRCMB Articles in Press. Published on 29-October-2014 as 10.1165/rcmb.2014-0092OC 
 Copyright © 2014 by the American Thoracic Society 
16  
attenuated cell death and evidence of cytotoxicity in H2O2-challenged mouse lung 
microvascular endothelial cell monolayers and ROS-injured isolated perfused mouse 
lungs, respectively (27). Post-treatment with the sGC activator BAY 58-2667 in a mouse 
model of endotoxic shock reduced hypothermia and IL-6 levels, and attenuated 
cardiomyocyte apoptosis, heart rate and mortality (28). Such effects of sGC signalling 
could also be mediating the protective role of the sGC in the RB-induced lung injury. 
 
In summary, we have shown RB induces downregulation of the sGC in the lung 
and acute lung injury. Pharmacological restoration of the sGC/cGMP pathway reverses 
the observed lung injury. Our results open the interesting possibility that sGC stimulation 
can be used in clinical conditions of severe RB i.e asthma attacks and COPD 
exacerbations. sGC stimulators have been successfully used in patients with chronic 
thromboembolic pulmonary hypertension and pulmonary arterial hypertension (29, 30). 
Our current findings and the findings of our previous study (4) suggest that sGC 
signalling restoration is worth investigating in both stable and exacerbated obstructive 
lung diseases. 
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FIGURES 
 
 
 
Figure 1: Tracheal banding induces lung injury. A.Tracheal banding induces 
inflammatory cells influx in the BALF. Total cells and macrophages in BALF of TB mice 
are increased compared to sham operated mice (control) following 24 hours of resistive 
breathing. B. Neutrophils, lymphocytes and eosinophils (B1) influx in BALF of TB mice. 
C. Tracheal banding increases BALF protein concentration. Tracheal banding increases 
BALF concentration of cytokines : D. TNF-α. E. Interleukin-6 F. Intereleukin-1β. G. 
Lung histological evaluation by light microscopy revealed the existence of neutrophil 
infiltration in mice 24 hours after tracheal banding. RB increases interstitial and 
intraalveolar infiltration and focal congestion in the lung tissue. H. Representative 
histological section stained with hematoxylin-eosin of quietly breathing (control) and 
treated mice, after tracheal banding, respectively. Note that, following 24 hours of 
tracheal banding, intra-alveolar and interstitial infiltration of inflammatory cells, focal 
thickening and capillary congestion occur. 
Respiratory System Mechanics: I. Tissue resistance by force oscillation technique is 
elevated following tracheal banding. J. Tissue elasticity is elevated following tracheal 
banding. K. Static compliance of the respiratory system was decreased 24 hours after 
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tracheal banding. Values are expressed as means ± SEM; n=10; *p< 0.05 from sham 
operated (control) group. 
 
 
 
Figure 2: The expression of sGC is decreased in the lungs of TB mice. A. cDNA 
samples from total RNA of sGCα1 and β1 subunits, extracted from homogenized mice 
lung were used and PCR amplifications were performed in triplicate. 18S and GAPDH 
amplification was used as the endogenous control. B. RB decreased cGMP production in 
BALF collected 24 hours after tracheal banding C. Protein levels of sGC subunits are 
decreased in mice after 24 hours of resistive breathing. Sham operated (control) or TB 
(TB) mice were sacrificed 24hours after treatment. Representative western blots for the 
α-1, β-1 and β-actin. D. Blots were quantified by densitometry. Expression for each 
subunit normalized for β-actin was set at 100% for sham operated mice. Values are 
expressed as means ± SEM; n=10; *p< 0.05 from sham operated (control) group. 
 
 
 
Figure 3: Inhibition of sGC activity by ODQ worsens RB-induced lung injury. A. 
Exposure of animals to the nebulised ODQ, aggravates the effect of tracheal banding by 
increasing BALF inflammatory cell number. B. ODQ inhalation worsens the effect of 
tracheal banding on albumin leakage. 
ODQ aggravates lung histopathology after tracheal banding. C. Lung histological 
evaluation by light microscopy revealed a worse inflammation and neutrophil infiltration 
in TB mice treated with ODQ compared to the TB group. Inhalation of ODQ increased 
interstitial and intraalveolar infiltration and focal congestion in the lung tissue, compared 
to the TB group. D. Representative histological section stained with hematoxylin-eosin of 
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quietly breathing (control) and TB (TB) mice, with or without exposure to ODQ, 
respectively. 
ODQ aggravates lung mechanics after tracheal banding E. Elevated tissue elasticity, 
following tracheal banding, was further increased after inhalation of ODQ. F. The 
decrease of the static compliance of the respiratory system, 24hs after tracheal banding 
was further attenuated after inhalation of ODQ. Values are expressed as means ± SEM; 
n=10; *p< 0.05 from sham operated (control) group and # p<0.05 from TB group. 
 
 
 
Figure 4: sGC α1 deficiency in mice aggravates lung injury caused by tracheal banding 
(TB). A. sGC α1-/- mice subjected to tracheal banding, aggravates the effect of TB by 
increasing BALF inflammatory cell number. B. sGC α1 deficiency worsens the effect of 
tracheal banding on albumin leakage. C. Lung histological evaluation by light 
microscopy in sGC α1-/- and WT mice subjected to TB. D. Representative histological 
section stained with hematoxylin-eosin of quietly breathing (control) and TB sGC α1-/- 
and WT mice. E. Elevated tissue elasticity, following tracheal banding, was further 
increased in sGC α1-/-. F. The decrease of the static compliance of the respiratory 
system, 24 hourss after tracheal banding was further attenuated in sGC α1-/-. Values are 
expressed as means ± SEM; n=8; *p< 0.05 from sham operated (control) group and # 
p<0.05 from TB group of WT mice. 
 
 
 
Figure 5. Activation of sGC attenuates lung injury caused by tracheal banding- 
Prophylactic protocol. A. Administration (i.p.) of BAY 58-2667 30min prior to tracheal 
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banding, reversed the effect of RB by reducing BALF inflammatory cell number. B. 
 
BAY 58-2667 attenuated the effect of RB on albumin leakage. 
 
Activation of sGC improves lung histopathology after tracheal banding.C. Lung 
histological evaluation by light microscopy revealed the attenuation of inflammation and 
neutrophil infiltration in mice treated with BAY 58-2667 prior to tracheal banding. BAY 
58-2667 decreased interstitial and intraalveolar infiltration and focal congestion in the 
lung tissue, compared to the group of TB (TB) mice. D. Representative histological 
section stained with hematoxylin-eosin of quietly breathing and TB (TB) mice, with or 
without BAY 58-2667, respectively. Note that intralveolar and interstitial infiltration of 
inflammatory cells, focal thickening and capillary congestion that occurs following 
tracheal banding, is attenuated when BAY 58-2667 is administrated prior to TB. 
Activation of sGC improves lung mechanics after tracheal banding. E. Elevated 
airway resistance and F. tissue elasticity, following tracheal banding, was attenuated 
when BAY 58-2667 was administrated prior to TB. Values are expressed as means ± 
SEM; n=10; *p< 0.05 from sham operated (control) group and # p<0.05 from TB group. 
 
 
 
Figure 6: Therapeutic activation of sGC attenuates lung injury caused by tracheal 
banding-Therapeutic protocol A. Administration (i.p.) of BAY 58-2667 24 hrs after 
tracheal banding reversed the effect of RB by reducing BALF inflammatory cell number. 
B. BAY 58-2667 attenuated the effect of RB on albumin leakage. 
 
Activation of sGC improves lung histopathology after tracheal banding. C. Lung 
histological evaluation by light microscopy revealed the attenuation of inflammation and 
neutrophil  infiltration  in  mice  treated  with  BAY  58-2667.  BAY  58-2667  decreased 
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interstitial and intraalveolar infiltration and focal congestion in the lung tissue, compared 
to the group of TB (TB) mice. D. Representative histological section stained with 
hematoxylin-eosin of quietly breathing and TB (TB) mice, with or without BAY 58- 
2667, respectively. Note that intralveolar and interstitial infiltration of inflammatory cells, 
focal thickening and capillary congestion that occurs following tracheal banding, is 
attenuated when BAY 58-2667 is administrated 24hrs after TB. 
Activation of sGC improves lung mechanics after tracheal banding. E. Elevated 
airway resistance and F. tissue elasticity, following tracheal banding, was attenuated 
when BAY 58-2667 was administrated after TB. Values are expressed as means ± SEM; 
n=10; *p< 0.05 from sham operated (control) group and # p<0.05 from TB group. 
 
 
 
Figure 7: A schematic overview of the RB-induced lung injury. Resistive breathing 
(RB) increased (↑) IL-6, TNF-α and IL-1β in the BALF. In the lung tissue RB reduced 
expression (↓) of soluble guanylyl cyclase (sGC) followed by reduced (↓) cyclic 
guanosine monophosphate (cGMP) generation and reduced cGMP-dependent protein 
kinase (PKG) function as reflected by attenuation of lung injury using a PKG activator, 
8pCPTcGMP. The sGC downstream signalling is mainly determined by 
phosphodiesterases (PDE)-5A which hydrolyses cGMP to GMP, in a negative feed-back 
regulation. The impaired sGC/cGMP/PKG signalling pathway contributes to lung injury 
as reflected by elevated BAL cellularity, protein and cytokine content, pathological 
evaluation and derangement of respiratory system mechanics. Administration of BAY 58- 
2667 activated sGC and attenuated lung injury due to resistive breathing. 
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On line data supplement 
Guanylyl cyclase activation reverses resistive breathing induced lung injury and 
inflammation 
Constantinos Glynos, Dimitris Toumpanakis, Konstantinos Loverdos, Vassiliki 
Karavana, Zongmin Zhou, Christina Magkou, Maria Dettoraki, Fotis Perlikos, 
Athanasia Pavlidou, Vasilis Kotsikoris, Stavros Topouzis, Stamatios E. Theocharis, 
Peter Brouckaert, Athanasios Giannis, Andreas Papapetropoulos and Theodoros 
Vassilakopoulos. 
 
Methods  
Reagents: Reagents for SDS-polyacrylamide gel electrophoresis and western blotting 
were obtained from Biorad (Hercules, CA). The Supersignal Chemiluminescent 
Substrate was obtained from Pierce (Rockford, Illinois). X-ray film was obtained 
from Eastman Kodak (Rochester, NY). Rabbit polyclonal antibodies against sGCα1 
and β-actin were purchased from Sigma-Aldrich (St Luis, MO), the anti-sGCβ1 
antibody was obtained from Cayman Chemicals (Ann Arbor, MI). The anti-rabbit 
HRP-labeled secondary antibody for western blotting was purchased from NEN Life 
Science Products, Inc (Boston, MA). Bronchoalveolar lavage fluid levels of tumour 
necrosis factor (TNF)-α, interleukin (IL)-1β, or IL-6 were measured with 
commercially available enzyme-linked immunosorbent assay kits (HS Quantikine; 
R&D Systems, Minneapolis, MN) according to the manufacturer’s instructions. All 
other reagents, including SYBRGreen I, LPS Pseudomonas aureginosa serotype 10, 
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1H-[1, 2, and 4] oxodiazolo [4, 3-α] quinoxalin-l-one (ODQ), and 8pCPTcGMP were 
obtained from Sigma-Aldrich (St Louis, MO). 
Study Design: Eight-to-twelve-week old male C57BL/6 mice, weighing 16–24 g 
were used were purchased from Pasteur Institute (Athens, Greece). sGCα1-/- mice 
were provided by the SPF facility of the Department of Molecular Biomedical 
Research, VIB, Ghent, Belgium. sGCα1-/- mice were generated on a mixed 
129S6/Swiss background as previously described (1) and backcrossed for at least 10 
generations to the C57BL/6J background (2). sGCα1-/- mice carry a targeted deletion 
of the sixth exon of the gene encoding sGCα1, resulting in the expression of a mutant, 
catalytically inactive protein. Mice were maintained in standard conditions under a 
12-hour light-dark cycle, provided a standard diet and chlorinated tap water ad 
libitum. All procedures were in accordance to European Union Directive for care and 
use of laboratory animals and were approved by the Greek Veterinary Administration 
and the ethical committee of Evangelismos Hospital.  
Tracheal Banding protocol: After general anaesthesia with intraperitoneal xylazine 
(5 mg/kg) and ketamine (90 mg/kg) ip, and sterile preparation, mice were placed 
under a visual microscope. An anterior cervical incision was made and segment of the 
extrathoracic trachea was exposed. The outer diameter of the trachea was measured 
with a calliper gauge and the area surface was calculated. The new perimeter of the 
trachea was calculated to provide a surface area half of the initial, by placing around 
the trachea a sterile nylon band of the adequate length equal to the calculated 
perimeter. The band was sutured firmly in place and the animal returned to cage after 
suturing the excision of the skin provided tracheal occlusion. Sham surgery of control 
mice consisted of anaesthesia, a neck incision, and tracheal dissection without 
banding. Animals were sacrificed 24 hrs after treatment. 
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Respiratory System Mechanics: The function of the respiratory system after tracheal 
banding was estimated with the use of the forced oscillation technique and by 
performing static pressure volume curves, as previously described(3). Following 
tracheal banding, the animals were anaesthetized with an intraperitoneal injection of 
ketamine (100 mg/kg) and xylazine (10 mg/kg). An anterior cervical incision was 
performed, the nylon band was removed and the animals were tracheostomized below 
the level of banding with a tracheal cannula (20G). Following, the animals were 
connected to a small animal ventilator (Scireq, Montreal, Canada) and ventilated with 
a 7 ml.kg-1 tidal volume, 150 breaths x min
-1
 and the end expiratory pressure was set 
to 3 cmH20. Following three minutes of ventilation, an ip injection of succinylcholine 
(8 mg/kg) was performed, to cease spontaneous breathing and after one minute, three 
forced oscillation perturbations were performed, with one minute interval, to estimate 
lung mechanics. A static pressure volume curves was also constructed following one 
minute of ventilation after the last oscillation perturbation. Results from repeated 
measures in every animal were averaged. Prior to measurements (30 sec) the lung 
volume history was once standardized by one inflation to total lung capacity, as 
estimated by airway opening pressure at 30 cmH20. During ventilation, the heart rate 
was monitored to ensure adequate depth of anaesthesia.  
Forced Oscillation Technique: The forced oscillation perturbation consists of a 
pseudorandom waveform of low frequencies (0.5-19.75 Hz) applied for 8 seconds 
with a peak to peak volume of 3 ml/kg. Pressure and volume data are recorded and the 
impedance of the respiratory system is calculated using the Fast Fourier 
transformation. Impedance (Z) is then fitted to constant phase model : Zrs(f) = Rn + 
i2πfI + (G-iH)/(2πf)a, where Rn is the Newtonian resistance of the airways, i is the 
imaginary unit, f is the frequency, I is the inertance of the gas in the airways, G 
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represents tissue viscance (viscous dissipitation of energy) and H represents tissue 
elasticity and alpha can be calculated through the equation α = (2/π)arctan(H/G). Data 
were accepted only when the Coefficient of Determination (fit of the model) was 
more than 0.9. Static Pressure Volume Curve: Static pressure volume curves of the 
respiratory system were performed by gradually inflating and deflating the lungs with 
a total volume of 40 ml/kg at seven steps each. The static compliance of the 
respiratory system was estimated by the slope of the mid linear part in the expiratory 
limb of the PV curve. Hysteresis (area between inspiratory and expiratory limb) was 
automatically calculated (FlexiVent software)(3). 
Bronchoalveolar lavage fluid: Following 24 hrs of tracheal banding, the animals 
were sacrificed by exsanguination (vena cava dissection) following anaesthesia with 
ketamine (100mg/kg) and xylazine (10mg/kg) ip. After exsanguinations, the trachea 
was cannulated with a 20 gauge plastic catheter. Lungs were lavaged by infusing 1 
mL warm saline, three sequential times. The recovered bronchoalveolar lavage fluid 
(BALF) was centrifuged; cells were collected and resuspended in PBS. Differential 
BALF cell counts were performed on Giemsa-stained cytospins and percentages of 
eosinophils lymphocytes, neutrophils and macrophages were determined. Protein 
concentration was measured in the BALF using the Lowry method, employing bovine 
serum albumin as a standard. TNF-α, IL-1β, and IL-6 levels were measured with 
ELISA from BAL fluid supernatant with the standard protocol supplied by the 
manufacturer (R & D systems). 
Lung Histology: Following bronchoalvolar lavage, the left lung was harvested from 
mice and immersed in 4% formaldehyde solution. The tissue was embedded in 
paraffin wax, serially sectioned, and stained with hematoxylin-eosin, using standard 
methods. Two pathologists blinded for treatment evaluated the histopathological 
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findings in the lung. A scoring system to grade the degree of lung inflammation have 
been used based on the following histological features: (i) capillary congestion, (ii) 
intra-alveolar haemorrhage, (iii) interstitial neutrophil infiltration, (iv) intra-alveolar 
neutrophil infiltration, (v) focal thickening of alveolar membranes. A scale from 0 to 
3 for each feature will be used (0: absence, 1: mild, 2: moderate, 3: most severe) (4). 
cGMP measurements: To determine whether RB effect on sGC activity we 
measured cGMP production in BALF collected 24hrs after tracheal banding. Cells 
were pelleted, washed twice, and incubated in Hanks’ balanced salt solution for 15 
min; cells were then lysed with 0.1 N HCl, and cGMP levels were analyzed in the 
extracts using a commercially available enzyme immunoassay kit following the 
manufacturer’s instructions (Direct cGMP Elisa Kit; Enzo Life Sciences, Lausen, 
Switzerland). 
Quantitative real-time PCR: Quantitative real-time PCR: Total cellular RNA was 
isolated using the Rneasy Mini Kit isolation method (Qiagen) and quantified on a 
NanoDrop 2000 (Thermo Scientific). 500ng of total RNA reverse transcribed with the 
PrimeScript RT Reagent Kit (Takara). Real time PCR amplification performed with 
the KAPA SYBR Fast One-step qRT-PCR protocol (KapaBiosystems). Amplification 
and Real-Time fluorescence detection performed using the Rotor Gene 6000 
(Corbett). PCR amplifications were performed in triplicate. Primer sequences were as 
follows: sGCα1 subunit: sense, 5’-CGG AAA ATC AAT GTC AGC CC-3’, 
antisense, 5’-AGG GAA GTT TGG TGG AAG CTC-3’, sGCβ1 subunit: sense, 5’-
GCG GTA CTC TTG CCT GGA AG-3’, antisense, 5’-
GACCATAATTGCGGATCACCA-3’, 18SrRNA: sense, 5’-
GTAACCCGTTGAACCCCATT-3’, antisense: 5’-CATCCAATCGGTAGTAGCG-
3’, GAPDH: sense, 5’- ACC-ATC-TTC-CAG-GAG-CGA-GAC-3’, antisense, 5’-
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GCC-TCC-TCC-ATG-GTG-GTG-AA-3’. Reaction samples had a final volume of 20 
μL. Amplification conditions consisted of 30 seconds at 95◦C, followed by 35 cycles 
of: 3 seconds at 95
◦
C, 20 seconds at 59
◦
C, 2 seconds at 72
◦
C. 18S and GAPDH 
amplification was used as the endogenous control. Ct values were automatically 
calculated by the machine’s software and normalized to the endogenous control gene 
by using the 2-
ΔΔC
T method (5)  
Immunoblot analysis of sGC subunits: After sacrificing the mice, lung tissue was 
frozen in liquid nitrogen and stored at –80 °C until used. One lobe was homogenized 
in 10 volumes (w/v) of a lysis buffer containing 1% Triton-X, 1% SDS, 150mM 
NaCl, 50mM NaF, 1mM Na3VO4, 0.5% sodium deoxycholate, 1mM EDTA, 0,1mM 
EGTA and protease inhibitors (10 µg/ml aprotinin, 10 µg/ml pepstatin, and 20 mM 
PMSF). Samples were subjected to SDS-PAGE followed by blotting with antibodies 
against the α1 (1:5,000) or β1 (1:2,000) and visualized using a chemiluminescent 
substrate. Values obtained for the α1 and β1 sGC subunit were normalized for actin 
and presented as % of control (6-8). 
ODQ treatment: C57BL/6 mice were treated with inhaled ODQ (1H-[1, 2, 4] 
oxodiazolo [4, 3-] quinoxalin-l-one) or vehicle (inhaled DMSO 10 %.), 30 min before 
tracheal banding. The ODQ (5 mg ODQ diluted in 50μL DMSO and then further 
dissolved in 5 ml saline) and the vehicle were administered over a 20-minute period in 
a nebulisation chamber under continuous oxygen flow, 30 minutes prior to tracheal 
banding. Animals were sacrificed 24 hrs after treatment. 
 
8pCPT cGMP treatment: C57BL/6 mice were treated with inhaled 8pCPT cGMP or 
vehicle (inhaled DMSO 10 %.), 30 min before tracheal banding. The 8pCPT cGMP 
(10 mg 8pCPT cGMP diluted in 50μL DMSO and then further dissolved in 5 ml 
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saline) and the vehicle were administered over a 20-minute period in a nebulisation 
chamber under continuous oxygen flow, 30 minutes prior to tracheal banding. 
Animals were sacrificed 24 hrs after treatment. 
BAY 58-2667 treatment: In the pharmacological experiment of RB, C57BL/6 mice 
were treated with the sGC activator BAY 58-2667 (4-[((4-carboxybutyl) {2-[(4- 
phenethylbenzyl) oxy] phenethyl} amino) methyl [benzoic] acid) (10 μg/kg, i.p.) or 
vehicle (DMSO 10%, i.p.). BAY58-2667 was synthesized as previously described(9). 
Prophylactic protocol:  wild type C57BL/6 mice were treated with the sGC activator 
BAY 58-2667 (10μg/kg, i.p.) 30 min before tracheal banding. Mice were sacrificed 24 
hrs after tracheal banding. Therapeutic protocol: mice were treated with the sGC 
activator BAY 58-2667 (10μg/kg, i.p.) 24 hrs after tracheal banding. Mice were 
sacrificed 30 hrs after tracheal banding. 
Statistical Analysis. Results are presented as means± SEM of the number of 
observations. Statistical analysis was performed with Sigma Stat software (SPSS 11.5, 
Chicago, IL, USA) using nonparametric tests for continuous variables (Kruskall-
Wallis, Mann-Whitney U). Differences were considered significant when p<0.05. 
 
 
Figure Legends   
Figure E1: The murine model of tracheal banding. A. After general anesthesia mice 
were placed under a visual microscope and an anterior cervical incision was made for 
trachea dissection. B. After the dissection, the extrathoracic segment of the trachea 
was exposed for perimeter calculation. C. The outer diameter of the trachea was 
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measured with a caliper gauge and the area surface was calculated. A new perimeter 
of the trachea has been calculated to provide a surface area half of the initial. D. A 
sterile nylon band of the adequate length equal to the calculated perimeter was placed 
around the trachea. E. and F. The band was sutured firmly in place to provide tracheal 
occlusion. The animal returned to cage after suturing the excision of the skin. 
Figure E2: Protein levels for the Phosphodiesterase (PDE)-5A are increased in the 
lungs of TB mice. Protein levels of the PDE5A were increased in mice after 24 hrs of 
resistive breathing. Sham operated (control) or TB (TB) mice were sacrificed 24hrs 
after treatment. Representative western blots for the PDE5A and β-actin. Blots were 
quantified by densitometry. Expression for each subunit normalized for β-actin was 
set at 100% for sham operated mice. Values are expressed as means ± SEM; n=5; *p< 
0.05 from sham operated (control) group. 
Figure E3: Restoration of sGC downstream signalling:  PKG activation attenuates 
lung injury caused by tracheal banding. To elucidate whether the restoration of sGC 
downstream signalling protects from the RB induced-lung injury, 8pCPTcGMP, a 
cell-membrane permeable analogue of cGMP, was administered by nebulisation 
30min prior to RB A. Exposure of animals to the nebulised 8pCPTcGMP, partially, 
reversed the effect of tracheal banding by reducing BALF inflammatory cell number. 
B. 8pCPTcGMP inhalation attenuated the effect of tracheal banding on albumin 
leakage. C. Lung histological evaluation by light microscopy revealed the attenuation 
of inflammation and neutrophil infiltration in mice treated with 8pCPTcGMP. 
Inhalation of 8pCPTcGMP decreased interstitial and intraalveolar infiltration and 
focal congestion in the lung tissue, compared to the group of TB (TB) mice. D. 
Representative histological section stained with hematoxylin-eosin of quietly 
breathing (control) and TB (TB) mice, with or without exposure to 8pCPTcGMP, 
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respectively. Note that intralveolar and interstitial infiltration of inflammatory cells, 
focal thickening and capillary congestion that occurs following tracheal banding, is 
attenuated after 8pCPTcGMP inhalation. E. Elevated tissue elasticity, following 
tracheal banding, was attenuated after inhalation of PKG activator F. The decrease of 
the static compliance of the respiratory system, 24hs after tracheal banding was 
reversed after inhalation of PKG activator. Values are expressed as means ± SEM; 
n=10; *p< 0.05 from sham operated (control) group and # p<0.05 from TB group. 
Figure E4: PKG activation attenuates the increase in cytokines caused by tracheal 
banding. A. Tracheal banding increases BALF levels of TNF-α whereas 
8pCPTcGMP inhalation attenuated TNF-α levels. B. BALF levels of IL-6 were 
increased after tracheal banding compared to sham operated mice. Inhalation of 
8pCPTcGMP reduced Il-6 levels in the BAL fluid. C. BALF levels of IL-1β were 
increased after tracheal banding, whereas 8pCPTcGMP inhalation attenuated lung 
inflammation by reducing levels of IL-1β. Values are expressed as means ± SEM; 
n=10; *p< 0.05 from sham operated (control) group and # p<0.05 from TB group. 
Figure E5: BAY 58-2667 reversed the RB-induced attenuation of cGMP levels. 
Cyclic guanosine monophosphate (cGMP) levels in bronchoalveolar lavage (BAL) 
were attenuated 24 hrs after tracheal banding. A. Prophylactic and B. therapeutic 
administration of BAY 58-2667 reversed the RB-induced attenuation of cGMP levels. 
Values are expressed as means ± SEM; n=10; *p< 0.05 from sham operated (control) 
group. 
Figure E6: Schematic overview of the tracheal banding protocols: A. Pretreatment 
of mice with ODQ. Inhaled ODQ was administrated 30min prior to tracheal banding 
Animals were sacrificed 24 hrs after treatment B. Pretreatment of mice with 8pCPT 
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cGMP. Inhaled 8pCPT cGMP was administrated 30min prior to tracheal banding. 
Animals were sacrificed 24 hrs after treatment C. Prophylactic treatment with BAY 
58-2667. Administration (i.p.) of BAY 58-2667, 30min prior to tracheal banding. 
Animals were sacrificed 24 hrs after treatment D. Therapeutic treatment with BAY 
58-2667. Administration (i.p.) of BAY 58-2667, 24hrs after tracheal banding. 
Animals were sacrificed 30 hrs after treatment. 
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